X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

ICYMI: Why 2017 medicine approvals matter

By Andrew Powaleny  |    January 12, 2018
This week, the U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) released its 2017 New Drug Therapy Approvals report. Last year marked an extraordinary...   Read More

New report and event examine the new era of vaccines

By Andrew Powaleny  |    November 9, 2017
Today, leading minds will come together for an in-depth conversation centered on vaccines – their critical role in warding off disease, the innovative science powering breakthroughs in their...   Read More

A new era in cancer

By Andrew Powaleny  |    November 1, 2017
The last few years have seen unparalleled progress in cancer care, with breakthrough research driving major advances in diagnosis and treatment. Next week, on Wednesday, November 8, leading minds...   Read More

More than 85 medicines in development for Alzheimer’s disease

By Andrew Powaleny  |    September 21, 2017
When Brian Kursonis started “blanking out” for moments at a time, a scan revealed plaques of a protein called amyloid in the brain, one sign of Alzheimer’s disease. A test of his spinal fluid...   Read More

How biopharmaceutical collaboration is driving a new era of medicine

By Andrew Powaleny  |    September 7, 2017
Biopharmaceutical innovation, coupled with technological advancements, has brought a new era of medicine transforming how we research and develop new medicines to benefit patients.   Read More

Putting the bio in biotech: How Bay Area minds are powering biopharmaceutical innovation

By Andrew Powaleny  |    July 31, 2017
The Bay Area in California has long been considered a nucleus of innovation, having produced groundbreaking inventions and discoveries over the last few decades – spanning nearly every industry,...   Read More

Finding cures for incurable diseases

By Guest Contributor  |    July 25, 2017
By Sandra Raymond, president and CEO, The Lupus Foundation of America   Read More

New report portrays flourishing pipeline

By Gretta Stone  |    July 18, 2017
It’s an exciting time to be working in the biopharmaceutical industry. Almost every day new headlines highlight remarkable new advances in the fight against disease. Some have called this the...   Read More

Going boldly together: New advancements and new anniversaries

By Amber Lyons  |    July 11, 2017
Hopefully you’ve had the chance to meet Salim and Roxanne from our Together series on GoBoldly.com. Salim is an antirejection researcher and Roxanne had a heart transplant 7 years ago this week...   Read More

Examining the brain in The New Era of Medicine

By Andrew Powaleny  |    June 13, 2017
Biopharmaceutical innovation is powering a rapid pace of medical breakthroughs and scientific advancements.  America’s biopharmaceutical companies are working day in and day out to uncover new...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates